Accuray Incorporated (ARAY) News

Accuray Incorporated (ARAY): $1.58

0.01 (-0.63%)

POWR Rating

Component Grades








Filter ARAY News Items

ARAY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ARAY News Highlights

  • ARAY's 30 day story count now stands at 3.
  • Over the past 1 day, the trend for ARAY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • GAME, HD and TOP are the most mentioned tickers in articles about ARAY.

Latest ARAY News From Around the Web

Below are the latest news stories about ACCURAY INC that investors may wish to consider to help them evaluate ARAY as an investment opportunity.

Accuray (ARAY) Launches VitalHold in Japan for Use With Radixact

Accuray's (ARAY) VitalHold is likely to transform breast cancer treatment in Japan by integrating SGRT for precise radiotherapy. It may become a game-changer for patients and medical staff.

Yahoo | December 6, 2023

Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System

Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact® System in Japan beginning November 30, 2023. The VitalHold feature incorporates SGRT capability on the Radixact System using the Catalyst+ HD system manufactured by C-RAD, making it possible to deliver deep inspiration breath hold (DIBH) treatments, primarily for breast cancers, and perform markerless patient setup

Yahoo | December 5, 2023

Insider Sell Alert: President Suzanne Winter Sells 65,390 Shares of Accuray Inc (ARAY)

Accuray Incorporated (NASDAQ:ARAY), a company specializing in the development, manufacturing, and selling of radiotherapy systems for alternative cancer treatments, has recently witnessed a significant insider sell from one of its top executives.

Yahoo | December 5, 2023

Accuray Incorporated (NASDAQ:ARAY) Q1 2024 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY) Q1 2024 Earnings Call Transcript November 7, 2023 Accuray Incorporated reports earnings inline with expectations. Reported EPS is $-0.03 EPS, expectations were $-0.03. Operator: Good afternoon and welcome to the Accuray’s First Quarter 2024 Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to turn […]

Yahoo | November 8, 2023

Accuray (ARAY) Q1 Earnings In-Line With Estimates, Revenues Top

Accuray (ARAY) reports a solid fiscal first quarter top line on the back of robust Product revenues.

Yahoo | November 8, 2023

Q1 2024 Accuray Inc Earnings Call

Q1 2024 Accuray Inc Earnings Call

Yahoo | November 8, 2023

Compared to Estimates, Accuray (ARAY) Q1 Earnings: A Look at Key Metrics

The headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Yahoo | November 8, 2023

Accuray Reports Fiscal 2024 First Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023.

Yahoo | November 7, 2023

Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 14th Annual Jefferies London Healthcare Conference. The management team is scheduled to participate in a presentation with moderated Q&A on Wednesday, November 15th, 2023 at 9:00am GMT/4:00am EST.

Yahoo | October 31, 2023

The past five years for Accuray (NASDAQ:ARAY) investors has not been profitable

Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...

Yahoo | October 30, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!